A021501

Pancreas

Indiana University (IU)

• Indiana University Hospital / IU Simon Cancer Center

• Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial
  Katz MHG;Shi Q;Meyers J;Herman JM;Chuong M;Wolpin BM;Ahmad S;Marsh R;Schwartz L;Behr S;Frankel WL;Collisson E;Leenstra J;Williams TM;Vaccaro G;Venook A;Meyerhardt JA;O'Reilly EM;
• Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
  Katz MHG;Ou FS;Herman JM;Ahmad SA;Wolpin B;Marsh R;Behr S;Shi Q;Chuong M;Schwartz LH;Frankel W;Collisson E;Koay EJ;Hubbard JM;Leenstra JL;Meyerhardt J;O'Reilly E; ;
• Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501)
  Snyder RA;Zemla TJ;Shi Q;Segovia D;Ahmad SA;O'Reilly EM;Herman JM;Katz MHG;